Lall Marilyn M, Ferrell Jenny, Nagar Steve, Fleisher Lloyd N, McGahan M Christine
Department of Molecular Biomedical Sciences, North Carolina State University, 4700 Hillsborough Street, Raleigh, NC 27606, USA.
Invest Ophthalmol Vis Sci. 2008 Jan;49(1):310-9. doi: 10.1167/iovs.07-1041.
The authors previously published the novel finding that iron regulates L-glutamate synthesis and accumulation in the cell-conditioned medium (CCM) by increasing cytosolic aconitase activity in cultured lens epithelial cells (LECs), retinal pigment epithelial (RPE) cells, and neurons. The present study was designed to determine whether iron-induced L-glutamate accumulation in the CCM regulates L-cystine uptake and glutathione (GSH) levels through the aconitase pathway in LECs and RPE cells.
The presence of xCT, the light chain of X(c)(-), a glutamate/cystine antiporter, was analyzed by RT-PCR, immunoblotting, and immunocytochemistry. Uptake of L-[(35)S]cystine and L-[(3)H]glutamate was measured in the presence or absence of transporter inhibitors. L-cystine uptake and intracellular GSH concentration were measured in the presence or absence of iron-saturated transferrin, the iron chelator dipyridyl (DP), or oxalomalic acid (OMA), an aconitase inhibitor.
LECs and RPE cells express xCT, as evidenced by RT-PCR analysis and immunoblotting. xCT was localized by immunocytochemistry. The authors found that the iron-induced increase in L-glutamate availability increased L-cystine uptake, with subsequent increases in GSH levels. In addition, L-glutamate production, L-cystine uptake, and GSH concentration were inhibited by OMA and DP, indicating a central role for iron-regulated aconitase activity in GSH synthesis in LECs and RPE cells.
These results demonstrate for the first time that iron regulates L-cystine uptake and the downstream production of GSH in two mammalian cell types. It is possible that the increase in intracellular antioxidant concentration induced by iron serves as a protective mechanism against the well-established capacity of iron to induce oxidative damage.
作者之前发表了一项新发现,即铁通过增加培养的晶状体上皮细胞(LECs)、视网膜色素上皮(RPE)细胞和神经元中的胞质乌头酸酶活性,来调节细胞条件培养基(CCM)中L-谷氨酸的合成和积累。本研究旨在确定CCM中铁诱导的L-谷氨酸积累是否通过乌头酸酶途径调节LECs和RPE细胞中L-胱氨酸的摄取及谷胱甘肽(GSH)水平。
通过逆转录聚合酶链反应(RT-PCR)、免疫印迹和免疫细胞化学分析谷氨酸/胱氨酸反向转运体X(c)(-)的轻链xCT的存在情况。在有或没有转运体抑制剂的情况下测量L-[(35)S]胱氨酸和L-[(3)H]谷氨酸的摄取。在有或没有铁饱和转铁蛋白、铁螯合剂联吡啶(DP)或乌头酸酶抑制剂草酰苹果酸(OMA)的情况下测量L-胱氨酸摄取和细胞内GSH浓度。
RT-PCR分析和免疫印迹证明LECs和RPE细胞表达xCT。通过免疫细胞化学对xCT进行定位。作者发现铁诱导的L-谷氨酸可用性增加会增加L-胱氨酸摄取,随后GSH水平升高。此外,OMA和DP抑制L-谷氨酸产生、L-胱氨酸摄取和GSH浓度,表明铁调节的乌头酸酶活性在LECs和RPE细胞的GSH合成中起核心作用。
这些结果首次证明铁在两种哺乳动物细胞类型中调节L-胱氨酸摄取和GSH的下游产生。铁诱导的细胞内抗氧化剂浓度增加可能作为一种保护机制,对抗铁诱导氧化损伤的既定能力。